 Allison Shapiro
Concepts (161)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Adiposity | 9 | 2022 | 518 | 1.670 |
Why?
| | Maternal Nutritional Physiological Phenomena | 5 | 2023 | 176 | 1.480 |
Why?
| | Feeding Behavior | 4 | 2025 | 654 | 1.480 |
Why?
| | Diabetes Mellitus, Type 2 | 5 | 2024 | 2531 | 1.010 |
Why?
| | Caregivers | 2 | 2025 | 877 | 0.990 |
Why?
| | Infant Nutritional Physiological Phenomena | 2 | 2025 | 146 | 0.990 |
Why?
| | Cognition | 8 | 2024 | 1153 | 0.970 |
Why?
| | Obesity | 9 | 2022 | 2992 | 0.960 |
Why?
| | Family Characteristics | 2 | 2025 | 191 | 0.900 |
Why?
| | Prenatal Exposure Delayed Effects | 7 | 2024 | 605 | 0.880 |
Why?
| | Insulin Resistance | 3 | 2024 | 1208 | 0.820 |
Why?
| | Diet | 6 | 2025 | 1278 | 0.810 |
Why?
| | Overweight | 2 | 2020 | 558 | 0.810 |
Why?
| | Language Development | 2 | 2024 | 61 | 0.780 |
Why?
| | Prenatal Nutritional Physiological Phenomena | 3 | 2017 | 59 | 0.780 |
Why?
| | Insulin | 5 | 2024 | 2409 | 0.750 |
Why?
| | Executive Function | 3 | 2024 | 451 | 0.730 |
Why?
| | Hunger | 2 | 2019 | 45 | 0.730 |
Why?
| | Birth Weight | 10 | 2024 | 516 | 0.710 |
Why?
| | Prediabetic State | 1 | 2024 | 253 | 0.700 |
Why?
| | Mothers | 5 | 2024 | 754 | 0.670 |
Why?
| | Blood Glucose | 6 | 2022 | 2186 | 0.640 |
Why?
| | Adipogenesis | 2 | 2016 | 55 | 0.620 |
Why?
| | Umbilical Cord | 3 | 2017 | 85 | 0.560 |
Why?
| | Brain | 2 | 2020 | 2668 | 0.550 |
Why?
| | Niacin | 1 | 2017 | 17 | 0.550 |
Why?
| | Reward | 1 | 2019 | 244 | 0.510 |
Why?
| | Body Composition | 6 | 2017 | 684 | 0.510 |
Why?
| | Pregnancy | 17 | 2024 | 6763 | 0.490 |
Why?
| | Diet, High-Fat | 1 | 2017 | 247 | 0.490 |
Why?
| | Niacinamide | 1 | 2016 | 82 | 0.490 |
Why?
| | Child, Preschool | 12 | 2025 | 11074 | 0.440 |
Why?
| | Body Mass Index | 11 | 2024 | 2389 | 0.410 |
Why?
| | Diabetes, Gestational | 1 | 2017 | 318 | 0.390 |
Why?
| | Cannabidiol | 2 | 2024 | 119 | 0.370 |
Why?
| | Diabetes Mellitus, Type 1 | 3 | 2023 | 3715 | 0.370 |
Why?
| | Health Behavior | 1 | 2017 | 762 | 0.360 |
Why?
| | Magnetic Resonance Imaging | 2 | 2020 | 3566 | 0.350 |
Why?
| | Female | 28 | 2025 | 73304 | 0.340 |
Why?
| | Cannabinoids | 2 | 2023 | 161 | 0.330 |
Why?
| | Cohort Studies | 6 | 2021 | 5742 | 0.330 |
Why?
| | Infant, Newborn | 11 | 2024 | 6079 | 0.330 |
Why?
| | Infant | 10 | 2025 | 9465 | 0.310 |
Why?
| | Child Development | 3 | 2024 | 475 | 0.310 |
Why?
| | Plethysmography | 4 | 2017 | 106 | 0.300 |
Why?
| | Humans | 32 | 2025 | 137585 | 0.290 |
Why?
| | Adult | 16 | 2025 | 37929 | 0.290 |
Why?
| | Diet Surveys | 3 | 2017 | 95 | 0.290 |
Why?
| | Cognition Disorders | 2 | 2024 | 496 | 0.280 |
Why?
| | Longitudinal Studies | 6 | 2024 | 2844 | 0.280 |
Why?
| | Language | 2 | 2022 | 292 | 0.280 |
Why?
| | Biomarkers | 1 | 2019 | 4149 | 0.280 |
Why?
| | Male | 19 | 2025 | 67762 | 0.280 |
Why?
| | Child | 9 | 2024 | 21935 | 0.240 |
Why?
| | Cannabis | 2 | 2023 | 494 | 0.240 |
Why?
| | Young Adult | 9 | 2024 | 13209 | 0.230 |
Why?
| | Diabetic Neuropathies | 2 | 2023 | 94 | 0.230 |
Why?
| | PPAR gamma | 2 | 2016 | 182 | 0.230 |
Why?
| | Glucose Tolerance Test | 1 | 2024 | 366 | 0.200 |
Why?
| | Prospective Studies | 6 | 2023 | 7604 | 0.200 |
Why?
| | Vocabulary | 1 | 2022 | 38 | 0.190 |
Why?
| | Dronabinol | 1 | 2024 | 226 | 0.190 |
Why?
| | Adolescent | 8 | 2024 | 21513 | 0.190 |
Why?
| | Follow-Up Studies | 2 | 2024 | 5131 | 0.180 |
Why?
| | Educational Status | 1 | 2024 | 470 | 0.180 |
Why?
| | Diabetes Complications | 1 | 2023 | 227 | 0.180 |
Why?
| | Weight Gain | 2 | 2015 | 519 | 0.180 |
Why?
| | Hallucinogens | 1 | 2023 | 105 | 0.170 |
Why?
| | Food | 1 | 2022 | 164 | 0.170 |
Why?
| | Maternal Inheritance | 1 | 2020 | 16 | 0.170 |
Why?
| | Colorado | 7 | 2019 | 4565 | 0.170 |
Why?
| | Non-alcoholic Fatty Liver Disease | 1 | 2023 | 279 | 0.160 |
Why?
| | Insulin-Secreting Cells | 1 | 2024 | 377 | 0.160 |
Why?
| | Hyperphagia | 1 | 2019 | 34 | 0.150 |
Why?
| | Energy Intake | 2 | 2023 | 485 | 0.140 |
Why?
| | Cognitive Dysfunction | 1 | 2023 | 383 | 0.140 |
Why?
| | Maternal Exposure | 1 | 2019 | 190 | 0.140 |
Why?
| | Satiation | 1 | 2017 | 24 | 0.140 |
Why?
| | Fasting | 1 | 2019 | 281 | 0.140 |
Why?
| | Dietary Supplements | 1 | 2021 | 561 | 0.130 |
Why?
| | Tobacco Smoke Pollution | 1 | 2019 | 261 | 0.130 |
Why?
| | Neurodevelopmental Disorders | 1 | 2019 | 181 | 0.130 |
Why?
| | Cross-Sectional Studies | 2 | 2025 | 5472 | 0.130 |
Why?
| | Regression Analysis | 1 | 2019 | 1024 | 0.130 |
Why?
| | Sirtuin 1 | 1 | 2016 | 30 | 0.130 |
Why?
| | Infant, Small for Gestational Age | 1 | 2017 | 92 | 0.130 |
Why?
| | Fetal Development | 2 | 2016 | 296 | 0.120 |
Why?
| | AMP-Activated Protein Kinases | 1 | 2017 | 197 | 0.120 |
Why?
| | Pediatric Obesity | 3 | 2017 | 601 | 0.120 |
Why?
| | Sense of Coherence | 1 | 2015 | 11 | 0.120 |
Why?
| | Glycogen Synthase Kinase 3 | 1 | 2015 | 82 | 0.120 |
Why?
| | Dietary Carbohydrates | 1 | 2016 | 155 | 0.120 |
Why?
| | Socioeconomic Factors | 2 | 2017 | 1289 | 0.120 |
Why?
| | Homeostasis | 1 | 2019 | 621 | 0.120 |
Why?
| | Dietary Proteins | 1 | 2016 | 135 | 0.120 |
Why?
| | Fetal Blood | 1 | 2017 | 327 | 0.120 |
Why?
| | Lipids | 2 | 2021 | 672 | 0.120 |
Why?
| | Prenatal Care | 1 | 2017 | 294 | 0.110 |
Why?
| | Psychological Tests | 1 | 2015 | 140 | 0.110 |
Why?
| | Neuropsychological Tests | 1 | 2019 | 1023 | 0.110 |
Why?
| | Dietary Fats | 1 | 2016 | 304 | 0.110 |
Why?
| | Fatty Acids | 1 | 2017 | 443 | 0.110 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2016 | 852 | 0.110 |
Why?
| | Vitamin D | 1 | 2017 | 397 | 0.110 |
Why?
| | Maternal-Fetal Exchange | 1 | 2015 | 165 | 0.110 |
Why?
| | beta Catenin | 1 | 2015 | 253 | 0.100 |
Why?
| | Linear Models | 4 | 2017 | 849 | 0.100 |
Why?
| | Polymerase Chain Reaction | 1 | 2016 | 1062 | 0.100 |
Why?
| | Risk Factors | 5 | 2021 | 10388 | 0.100 |
Why?
| | Gene Expression | 1 | 2017 | 1502 | 0.100 |
Why?
| | Parents | 1 | 2021 | 1347 | 0.100 |
Why?
| | DNA Methylation | 1 | 2017 | 643 | 0.100 |
Why?
| | Surveys and Questionnaires | 4 | 2017 | 5778 | 0.090 |
Why?
| | Smoking | 1 | 2019 | 1627 | 0.090 |
Why?
| | Pregnancy Complications | 1 | 2015 | 527 | 0.080 |
Why?
| | Blood Pressure | 1 | 2017 | 1786 | 0.080 |
Why?
| | Breast Feeding | 2 | 2024 | 440 | 0.080 |
Why?
| | Indians, North American | 1 | 2015 | 643 | 0.080 |
Why?
| | Energy Metabolism | 1 | 2015 | 922 | 0.070 |
Why?
| | Aged | 2 | 2024 | 23961 | 0.060 |
Why?
| | Muscle Development | 2 | 2017 | 111 | 0.060 |
Why?
| | Exercise | 1 | 2017 | 2057 | 0.060 |
Why?
| | Middle Aged | 2 | 2024 | 33479 | 0.050 |
Why?
| | Cardiovascular Diseases | 1 | 2015 | 2111 | 0.050 |
Why?
| | Sugars | 1 | 2023 | 41 | 0.050 |
Why?
| | Cell Differentiation | 2 | 2017 | 1991 | 0.040 |
Why?
| | Diabetic Retinopathy | 1 | 2021 | 189 | 0.040 |
Why?
| | United States | 1 | 2016 | 14841 | 0.040 |
Why?
| | Acetyl-CoA Carboxylase | 1 | 2017 | 33 | 0.030 |
Why?
| | Diabetic Nephropathies | 1 | 2021 | 294 | 0.030 |
Why?
| | Carnitine O-Palmitoyltransferase | 1 | 2017 | 46 | 0.030 |
Why?
| | Glucose | 1 | 2022 | 1020 | 0.030 |
Why?
| | Pregnancy Trimester, Second | 1 | 2017 | 80 | 0.030 |
Why?
| | Pregnancy Trimester, Third | 1 | 2017 | 114 | 0.030 |
Why?
| | Blood Pressure Determination | 1 | 2017 | 157 | 0.030 |
Why?
| | Glycogen Synthase Kinase 3 beta | 1 | 2015 | 72 | 0.030 |
Why?
| | Mental Recall | 1 | 2017 | 202 | 0.030 |
Why?
| | Lipoproteins, HDL | 1 | 2015 | 77 | 0.030 |
Why?
| | Health | 1 | 2015 | 84 | 0.030 |
Why?
| | Factor Analysis, Statistical | 1 | 2015 | 283 | 0.030 |
Why?
| | Gestational Age | 1 | 2017 | 910 | 0.030 |
Why?
| | Lipid Metabolism | 1 | 2017 | 518 | 0.030 |
Why?
| | Oral Health | 1 | 2015 | 124 | 0.030 |
Why?
| | Oxidation-Reduction | 1 | 2017 | 1060 | 0.030 |
Why?
| | Leptin | 1 | 2015 | 236 | 0.030 |
Why?
| | Multivariate Analysis | 1 | 2017 | 1509 | 0.030 |
Why?
| | Triglycerides | 1 | 2015 | 524 | 0.020 |
Why?
| | Incidence | 1 | 2019 | 2804 | 0.020 |
Why?
| | Metabolomics | 1 | 2017 | 678 | 0.020 |
Why?
| | Self Efficacy | 1 | 2015 | 396 | 0.020 |
Why?
| | Logistic Models | 1 | 2017 | 2074 | 0.020 |
Why?
| | Psychometrics | 1 | 2015 | 720 | 0.020 |
Why?
| | Oxidative Stress | 1 | 2017 | 1317 | 0.020 |
Why?
| | Membrane Proteins | 1 | 2017 | 1164 | 0.020 |
Why?
| | Gene Expression Profiling | 1 | 2017 | 1774 | 0.020 |
Why?
| | Adipose Tissue | 1 | 2014 | 635 | 0.020 |
Why?
| | Gene Expression Regulation | 1 | 2017 | 2607 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2015 | 4193 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2015 | 3284 | 0.020 |
Why?
| | Quality of Life | 1 | 2015 | 2892 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2015 | 7635 | 0.010 |
Why?
|
|
Shapiro's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|